Effect of magnesium chloride and magnesium L-aspartate on seizure threshold in rats under conditions of dietary magnesium deficiency

Bulletin of Experimental Biology and Medicine

Volumn 144, Issue 2, 2007, Pages 214-216

  Spasov, A A ^a   Iezhitsa, I N ^a   Kharitonova, M V ^a   Kravchenko, M S ^a  

^a VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Corazol; Magnesium chloride; Magnesium L aspartate; Pyridoxine; Seizures

Indexed keywords

MAGNESIUM ASPARTATE; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE; PENTETRAZOLE; PYRIDOXINE; PYRIDOXINE DERIVATIVE; PYRIDOXINE MAGNESIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL EFFECTIVENESS; CLONIC SEIZURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; HYPOMAGNESEMIA; LATENT PERIOD; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MALE; MONOTHERAPY; NONHUMAN; NUTRITIONAL DEFICIENCY; RAT; SEIZURE; SEIZURE THRESHOLD;

ANIMALS; ANTICONVULSANTS; ASPARTIC ACID; MAGNESIUM CHLORIDE; MAGNESIUM DEFICIENCY; MALE; PENTYLENETETRAZOLE; PYRIDOXINE; RATS; SEIZURES;

RATTUS;

EID: 36949016866     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0292-7     Document Type: Article

References (6)

1. Manual on Experimental (Preclinical) Study of New Pharmacological Substances [in Russian], Ed. R. U. Khabriev, Moscow (2005).
2. M. Derchansky, E. Shahar, R. A. Wennberg, et al., Hippocampus, 14, No. 8, 935-947 (2004).
3. V. R. Dharnidharka and P. R. Carney, Pediatr. Neurol., 33, No. 1, 61-65 (2005).
4. M. Firoz and M. Graber, Magnes. Res., 14, No. 4, 257-262 (2001).
5. P. Maurois, F. Bailly, N. Pages, et al., Advances in Magnesium Research: Nutrition and Health, Eastleigh (2001), pp. 419-422.
6. E. Planells, A. Lerma, N. Sanchez-Morito, et al., J. Am. Coll. Nutr., 16, No. 4, 352-356 (1997).